Nishio Machiko, Garcin Dominique, Simonet Viviane, Kolakofsky Daniel
Department of Genetics and Microbiology, University of Geneva School of Medicine, CMU, 9 Ave de Champel, CH1211, Geneva, Switzerland.
Virology. 2002 Aug 15;300(1):92-9. doi: 10.1006/viro.2002.1509.
Viruses of the Paramyxovirinae, similar to other viruses, have evolved specific proteins that interdict IFN action as part of a general strategy to counteract host innate immunity. In many (but not all) cases, this interdiction is accompanied by a lowering of the intracellular levels of the STAT proteins. Among rubulaviruses, there is a notable variation in how they interfere with IFN action. Whereas SV41, SV5, and MuV all act by lowering Stat1, hPIV2 acts by lowering Stat2. Here, we show that the mumps and hPIV2 V proteins both form a complex with several Stat proteins in a mixed-extract assay. This suggests that the specific degradation of these Stat proteins is not determined by complex formation, but presumably at some later stage of the degradation pathway. V/Stat complex formation requires a specific carboxyl segment of V. However, a previously unrecognized trp-rich motif, rather than the Zn(++)-binding cys-cluster of this segment, appears to be required for V/Stat interaction. The C protein of Sendai (respiro-) virus, another P gene encoded protein, also forms a complex with Stat1, and prebinding of MuV V to Stat1 prevents the subsequent binding of SeV C. Our results suggest that rubulavirus V proteins may be related to both the C and the V proteins of respiroviruses.
副黏病毒亚科的病毒与其他病毒一样,进化出了特定的蛋白质来阻断干扰素的作用,这是对抗宿主先天免疫的总体策略的一部分。在许多(但不是所有)情况下,这种阻断伴随着STAT蛋白细胞内水平的降低。在腮腺炎病毒属中,它们干扰干扰素作用的方式存在显著差异。虽然SV41、SV5和腮腺炎病毒都通过降低Stat1起作用,但人副流感病毒2型通过降低Stat2起作用。在这里,我们表明腮腺炎病毒和人副流感病毒2型的V蛋白在混合提取物试验中都与几种STAT蛋白形成复合物。这表明这些STAT蛋白的特异性降解不是由复合物形成决定的,而是可能在降解途径的某个后期阶段。V/STAT复合物的形成需要V的特定羧基段。然而,V/STAT相互作用似乎需要一个以前未被识别的富含色氨酸的基序,而不是该段的锌结合半胱氨酸簇。仙台(呼吸道)病毒的C蛋白是另一种由P基因编码的蛋白,也与Stat1形成复合物,腮腺炎病毒V与Stat1的预结合会阻止随后仙台病毒C的结合。我们的结果表明,腮腺炎病毒属的V蛋白可能与呼吸道病毒的C蛋白和V蛋白都有关。